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Summary Down syndrome (DS) is the most common chromosomal disorder resulting in various
abnormalities such as mental retardation, immunodeficiency and physical abnormities. Espe-
cially, abnormality of the immune function is important pathological features in this syndrome,
and leads to increased susceptibility to viral or bacterial infections. Interestingly, several studies
have showed that they have high susceptibility of severe periodontal disease, even though they
have lower or equal prevalence of dental caries. Many studies have attempted to clarify this
phenomenon but it remains unsolved. It is also well known that DS is a premature ageing
syndrome. DS has been considered as a model of precocious, abnormal ageing of immune function
in human. Age-related declines in immune function cause more susceptibility to infections in the
elderly. In addition, it is well known that ageing is related with telomere shortening. Further-
more, DS has an accelerated telomere shortening. However, there are only a few reports that
focus on the relations among ageing, telomere length and high susceptibility of oral infectious
disease in individuals with DS. Therefore, we summarize our current knowledge on the relations
between the oral disease and immunodeficiency in individuals with DS taking account of telomere
shortening and ageing.
# 2009 Japanese Association for Dental Science. Published by Elsevier Ireland. All rights reserved.
ava i lab le at www.sc ienced i rect .com
journal homepage: www.elsev ier .com/ locate / jdsr1. Introduction
Down syndrome (DS), a premature ageing syndrome, is a
chromosomal disorder caused by an error in cell division,* Corresponding author. Tel.: +81 47 360 9443; fax: +81 47 360 9443.
E-mail address: tanaka.yoko@nihon-u.ac.jp (Y. Tanaka).
1882-7616/$ — see front matter # 2009 Japanese Association for Denta
doi:10.1016/j.jdsr.2009.10.002resulting in the presence of an additional third chromosome
21 or ‘trisomy 21’ [1]. For this genetic disorder, DS results in a
characteristic spectrum of developmental abnormalities
affecting many organs and tissues [2]. It is known that DS
results in mental retardation, short stature, abnormalities
with cardiovascular, hematopoietic, musculoskeletal, ner-
vous, and behaviour anomaly. Therefore, many studies have
reported that individuals with DS have been prone to developl Science. Published by Elsevier Ireland. All rights reserved.
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also been demonstrated that individuals with DS have many
intraoral characteristics. According to Amano et al. [4], nine
major abnormal dental characteristics in individuals with DS
have been reported, including macroglossia, fissured tongue,
underdeveloped maxilla, tongue thrusting, congenitally
missing teeth, malocclusion, salivation, and microdontia
[5,6]. As well as these features, it is well known that they
have precipitation of a high calculus, severe periodontal
disease, and a lower prevalence of dental caries. Periodontal
disease and dental caries, which are themost common dental
disease for human, are both a chronic infection by bacteria of
normal oral flora. Namely, it is conceivable that individuals
with DS have an imbalance in host response to bacteria.
Several previous studies have suggested that genetic
abnormalities in their host responses, such as functional
defects in polymorphonuclear leukocytes, monocytes, and
lymphocytes, might be important contributing factors to the
high prevalence of periodontal disease in individuals with DS
[7—15]. Most have revealed that the prevalence of dental
caries in individuals with DS was lower than in normal indi-
viduals, or individuals with other causes of mental retarda-
tion [16,17], even if there have been some studies that held
an opposite view [18,19]. Thus, there is a diversity of views
on oral status in individuals with DS. Moreover, the question
why DS causes a high prevalence of periodontal disease and
low prevalence of dental caries in individuals with DS is still
unclear. Althoughmany studies have attempted to clarify this
phenomenon, there are few studies that focus on the relation
among oral infection, immune response and acceleration of
ageing in individuals with DS. Therefore, we summarize our
current knowledge on the relations between the oral disease
and immunodeficiency in individuals with DS taking account
of telomere shortening and ageing.
2. Oral status
It has been demonstrated that individuals with DS have many
intraoral features such as macroglossia, fissured tongue,
underdeveloped maxilla, tongue thrusting, congenitally miss-
ing teeth, malocclusion, salivation, microdontia, high preva-
lence of severe periodontal disease, and low prevalence of
dental caries. Above all, one of the most interesting is that
individuals with DS have a high prevalence of severe period-
ontal disease, even though they have lower prevalence of
dental caries. Dental caries and periodontal disease as well as
many diseases of themucousmembranes, tongue, and salivary
glands are infectious diseases. Lee et al. [20] reported that the
difference in the prevalence of caries between individuals
with DS and healthy controls was likely to depend on not the
diet and oral hygiene habits, the occlusal feature of the teeth,
and the interdental spaces, but on the immunoglobulin con-
centration level in the saliva. Further, Reuland-Bosma et al.
[11] showed that under identical conditions with respect to
food, hygiene and environment, a similar plaque development
gave rise to a more extensive gingival inflammation in a child
with DS than that in her sibling, They demonstrated that
helper/inducer cells on the tissue level in a child with DS were
stimulated earlier and during a longer period than those in her
sibling. According to thesefindings, it is conceivable that there
is an imbalance between inflammatory and anti-inflammatory
networks in individuals with DS.3. Salivary factors
It is well known that human saliva has been suggested to play
an important role in protection against noxious compounds
produced by microorganisms. In particular, secretory immu-
noglobulin A (sIgA) is major factor for the local host defence
against dental caries and periodontal diseases. Several stu-
dies have demonstrated the relationship between IgA and
periodontitis. Most studies have indicated that value of sIgA
in individuals with sever gingival inflammation were lower
than that in control [21]. In the generalized early-onset
periodontitis, which is associated with the periodontitis of
DS, a significantly lower concentration and secretion rate of
total salivary IgA has been observed [22]. In other hand, Lee
et al. [20] demonstrated that the individuals with DS had a
significantly higher level of specific antibodies against Strep-
tococcus mutans than the controls. Namely, it is suggested
that children with DS have a lower prevalence of dental
caries than normal children, whichmight be due to the higher
amounts of S. mutans-specific IgA antibodies, not total IgA.
Interestingly, Chaushu et al. [23] reported that whole saliva
flow in old individuals with DS significantly reduced compared
with young individuals with DS, while no statistically signifi-
cant differences were found in the whole saliva flow rate of
young control versus old control individuals. Although they
examined the flow rate in parotid, there was no dramatic
difference with age. They suggested that the secretory
immunity in the oral cavity of individuals with DS was char-
acterized by a severe immunodeficiency which was more
severe in whole saliva than in parotid saliva, and was extre-
mely exacerbated with age.
In general, the prevalence of infections derived from
mucosa appears to increase with age. In individuals with
DS, the prevalence and severity of mucosal gastrointestinal
and respiratory infections increases with ageing [3,24—28].
These infections are associated with complete or transient
deficiency of sIgA [3], although the levels of sIgA increase
with age [29]. It is well known that individuals with DS have
an acceleration of ageing. Thus, it is conceivable that an
increase of sIgA in individuals with DS is caused by accelera-
tion of ageing resulting from genetic abnormality. However,
Percival et al. [30] suggest that the ability to form IgA anti-
body responses is not impaired with increased age, and that
secretion rates and functional properties of antibodies may
be as important as concentrations in protection against
mucosal infective diseases. Although there are many reports
that support immunodeficiency in saliva with increased age in
individuals with DS, more sufficient evidence is required in
future studies to clarify the role of sIgA in oral infectious
disease.
4. Immune response
Although the reasons for an increased susceptibility to infec-
tions in individuals with DS are still not clear, it has been
showed that individuals with DS have a defect in immune
function resulting in an increased susceptibility to infections,
a high risk of malignancies, and a high frequency of auto-
immune phenomena [31—34]. Recently, several studies that
have focused on abnormalities of the immune system in
individuals with DS have been performed, demonstrating
80 Y. Tanaka et al.selective cell-mediated immunodeficiency, defective neu-
trophil polymorphonuclear leukocyte chemotaxis, and
impaired antibody response to specific pathogens, low T-cell
lymphocyte counts, and immature subsets of T lymphocytes
[17,35—37]. Burgio et al. [38] performed the immunologic
studies in 83 patients with DS in ages ranging from a few
months to 30 years old. They indicated that both thymus-
dependent and independent functions were impaired in
patients with DS. They also indicated that serum immuno-
globulin levels were normal in children with DS less than 5
years old, but a definite hyperglobulinemia of the IgG and IgA
type was observed after 6 years of age. Furthermore, high
levels of IgG1 and IgG3 were found, whereas a progressive
decline of IgG2 and IgG4 with age was observed [39]. Accord-
ing to Kusters et al. [40], these phenomena are supported by
a report that adults with DS have significantly higher per-
centages of interferon gamma-producing CD4+ and CD8+ cells
and a higher Th1/Th2 ratio [41]. T helper lymphocyte type 1
cells (Th1) stimulate cytotoxic T lymphocyte response and
IgG1 and IgG3 production, whereas T helper lymphocyte type
2 cells (Th2) stimulate antibody response by B lymphocyte
cells and formation of IgG2 and IgG4. On the other hand,
Cossarizza et al. [42] studied phenotype and proliferative
ability of peripheral blood lymphocytes (PBLs) in individuals
with DS. They indicated that a complex derangement of all
major peripheral blood cell subsets, i.e., B cells, Tcells, and
natural killer (NK) cells, was present in a higher percentage
of children with DS. A significant decrease of the absolute
number of circulating lymphocytes, a marked and significant
decrease of B lymphocyte absolute number and percentage,
and dramatic modifications of the T-cell subsets were
observed. The absolute number of CD4+ cells was signifi-
cantly decreased, whereas CD8+ cells increased significantly
in percentage but not in absolute number. Many of these
alterations are similar to those characteristics of chromoso-
mally normal subjects of advanced age [43]. Guazzarotti
et al. [44] reported that a complex skewing of post-thymic
lymphocyte maturation pathways was observed in individuals
with DS: significant reduction of CD4+ and CD8+ naive T
lymphocytes, significant increase of CD4+ and CD8+ central
memory T lymphocytes and terminally differentiated lym-
phocytes. DS is a premature ageing syndrome, and thus it is
conceivable that abnormal immuno response is in conse-
quence of accelerated ageing. Immuno responsiveness
undergoes a substantial decline with advancing age, parti-
cularly thymus-dependent immunity [45—48]. It is known
that age-related declines in immune function cause suscept-
ibility to infections resulting in increased morbidity and
mortality in the elderly as well as in individuals with DS. In
general, functions of T lymphocytes and B lymphocytes vary
with ageing. Haynes and Maue [49] reported that declines in
the function of CD4 T cells with ageing are thought to
contribute to the decline in high affinity antibody production
in the elderly. Age-related defect in CD4 Tcell differentiation
results in the generation of a group of T helper lymphocyte
(Th) cells with significantly reduced B cell helper activity
[50]. Therefore, it leads to reduce antibody production by B
cell resulting in high susceptibility to infections. Tam and
Walford [51] indicated that the cAMP/cGMP ratio for unsti-
mulated T cells declined in normal aged and DS subjects.
They indicated the existence of substantial age-related bio-
chemical changes in peripheral T cells. And they suggestedthat an imbalance in resting cyclic nucleotide levels and their
generating enzymes in Tcells of normal aging and DS subjects
might contribute to the immune dysfunction occurring both
with aging and in DS. It has been thought that there were
defects in B cells as well as in Tcells during ageing. Frasca and
Blomberg [52] indicated that elderly people have lower
percentages of CD19+ total B cells and Kusters et al. [40]
reported that a significant decrease of B lymphocytes
(CD19+) was observed in fetuses with DS.
As stated above, several studies have reported various
immunological theories and observations to explain the pre-
disposition of individuals with DS to various infections. Most
have focused on the abnormal role of the thymus in indivi-
duals with DS. Interestingly, Elsayed and Elsayed [53] focused
on the precocious aging theory which increased apoptosis.
Apoptosis plays a key role in tissue and organ development
during embryo genesis as well as in adult tissues during cell
turn-over. In adaptive immune response, after clearance of
the antigen, most of effective T cells undergo apoptosis and
only some survive to become long-lived memory T cell [54].
Elsayed et al. attempted to identify the effect of apoptosis on
both types of cells of specific immune response (T and B
lymphocytes) in children with DS using Annexin V staining
phosphatidyserine, which can detect early apoptosis. In their
work, both relative and absolute number of early apoptotic T
lymphocytes was significantly lower in children with DS,
while the absolute number of T lymphocytes was insignif-
icantly different. They concluded that increased early apop-
totic cells in children with DS might emphasize the fact that
the function of cell, and not their number, was the main
mechanism responsible for the impairment of the immune
system in children with DS.
There are two interesting studies about oral infections in
individuals with DS. Carlstedt et al. [55] studied the oral
carriage of Candida albicans (C. albicans) in 55 children and
adults with DS, aged between 7 months and 20 years 6
months. The number of subjects with colonized C. albicans
in oral cavity was significantly higher in the DS group than in
the control group, and the frequency of colonization with C.
albicans was positively correlated to age. They suggested
that abnormalities of the immune response in individuals
with DS might be contributed to the increased oral carriage
of C. albicans. According to Ribeiro et al. [56], who studied to
characterize the biological aspects of oral strains of C.
albicans in children with DS, all oral C. albicans isolated
were sensitive to the drug used and this characteristic was
also observed in C. albicans obtained from patients with
other immunodeficiencies such as HIV, cancer, and diabetes.
As ageing leads to a decline in the function of the immune
system, the prevalence of fungal infections, such as C.
albicans, increase dramatically among the aged population.
Thus it is conceivable that it is possible that the susceptibility
to the mucosal infections is caused not only by the innate
abnormal immune response, but also by acceleration of
ageing in individuals with DS.
Taken together, it is more likely that an abnormal immune
response in individuals with DS is congenital and is intrinsi-
cally deficient from the very beginning. However, several
previous studies have indicated that immune response
become deranged during ageing and it is conceivable that
immunodeficiency in individuals with DS is caused as a con-
sequence of precocious ageing in DS.
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Telomeres, chromosome ends consisting of highly conserved
TTAGGG repeats, become shorter with every cell division [57].
Themain function of telomeres is to cap the chromosome ends
to distinguish the chromosome ends from DNA breaks within
the genome [58]. Telomere shortening accompanying cell
division was shown to occur both in vitro and in vivo with
age reflecting the cumulative effect of cell division [59]. This
phenomenon was demonstrated in human fibroblasts [60],
hematopoietic stem cells [61], leukocytes [62], keratinocytes
[63], epithelial [64], and endothelial cells [65]. To produce
telomere elongation, an enzyme called telomerase exists.
Telomerase is a cellular reverse transcriptase and consists of
two essential components: (1) the telomerase RNA and (2)
telomerase reverse transcriptase (TERT) [66]. hTER (human
TER) provides the template for repeat synthesis and is con-
stitutively expressed in human cells, and most somatic cells
repress hTERT (human TERT) expression at the transcriptional
level [67]. Most somatic cells in adult organisms do not express
telomerase and this enzyme is active only in germ cells, during
embryogenesis, in adult stem cells and in activated immune
cells, suggesting that its activity is tightly regulated during
development and differentiation [68]. Most normal somatic
cells exhibit capacity for only a finite number of divisions in
vitro before reaching replicative senescence, a well-known
phenomenon called the Hayflick limit. Once telomeres are
critically shortened, cells cease to divide and become senes-
cent or undergo apoptosis. In other words, telomeres play an
essential role in determining the replicative lifespan of cells.
5.1. Telomeres and immunosenescence
It has been reported that increased telomere shortening has
been associated with a variety of conditions that include
replicative cellular senescence, apoptosis [57,69], osteoporo-
sis [70], and Down syndrome [71]. Moreover, Jiang et al. [72]
reported that individuals with short telomeres had an 8.54-
higher mortality rate from infectious disease compared to
those with relatively long telomeres. According to their
report, telomere shortening was observed in T lymphocytes
and progenitor/stem cell in individuals with DS [71,73]. In
addition, Vaziri et al. [74] showed a significantly higher rate of
telomere loss in peripheral blood lymphocytes (PBLs) in indi-
viduals with DS compared to those in control, and it was
accelerated with ageing. They also indicated that telomere
length of lymphocytes from centenarians and older individuals
with DS were similar to those of senescent lymphocytes in
culture, which suggests that replicative senescence could
partially account for ageing of the immune system in indivi-
duals with DS and in the elderly. Immunosenescence exert an
influence onmany components of the immune response, and it
has been indicated that accelerated telomere shortening of
lymphocytes was associated with the premature immunose-
nescence in individuals with DS [74,75].
5.2. Telomeres and fibroblasts
Telomere length has been determined in a variety of tissues
and it was observed that telomere length varies considerably
from tissue to tissue. Cells in different tissues differ enor-mously in their turnover rate and it is known that telomeres in
human fibroblast shorten 50—100 basepairs with each cell
division [57]. The replicative capacity of the cell is predicted
by initial telomere length as well as most somatic cells
[57,60].
We established gingival fibroblasts from individuals with
DS (DGF) which were immortalized by transduction with
hTERT gene (hTERT-DGF) using modified protocol of immor-
talized periodontal ligament cell [76]. DGF and hTERT-DGF
were stimulated with lipopolysaccharie (LPS) derived from
Prphyromonas gingivalis. We found that the production of
interleukin-6 in hTERT-DGF was significantly lower than that
in DGF in the presence of LPS (unpublished data). It is
conceivable that the effect of LPS was suppressed in DGF
produced telomere elongation because of hTERT transduc-
tion. However, we should hypothesize with circumspection.
There are two noteworthy studies. Kimura et al. [77]
explored cellular proliferation and senescence on cultured
skin fibroblasts from individuals with Down syndrome and
healthy individuals. They reported that there were no sig-
nificant differences of the cumulative number of population
doubling until replicative senescence and b-galactosidase
staining, which was known as a biomarker for cellular senes-
cence, between DS cells and control cells. Takahashi et al.
[78] reported that there were no significant differences in the
mean telomere length of PBL and human gingival fibroblasts
between the patients with aggressive periodontitis and the
controls. They suggested that aggressive periodontal disease
was not a disease of generalized accelerated aging and that
accelerated telomere loss was not a useful marker of pre-
mature immunosenescence of patients with aggressive per-
iodontal disease. Therefore, this is negative toward our
hypothesis which accelerated telomere shortening causes
severe periodontal disease in individuals with DS. However,
they did not study telomere length in DGF. And, according to
the previous papers, it is conceivable that telomere length
have an effect on immune response and other intracellular
functions. Furthermore, telomere length is sensitive to
genetic factors and environmental factors like chronic
inflammation and exposure to infectious agents. In addition,
as the investigation related with ageing and periodontal
disease is the beginning, there are few reports. Therefore,
further study will be needed.
5.3. Telomeres and oxidative stress
Presently, some studies indicate that chronic oxidative stress
plays amajor role in chronic inflammatory disease. Kawanishi
and Oikawa [79] investigated whether oxidative stress, which
contributed to aging, accelerated telomere shortening in
human cultured cells. Telomeres were demonstrated to be
highly sensitive to damage by oxidative stress due to their
high content of guanines. In addition, Passos [80] reported
that senescent cells had higher reactive oxygen species (ROS)
levels and indicated mitochondrial production of ROS as one
of the causes of replicative senescence. They suggested that
mitochondrial ROS was a major determinant of telomere-
dependent senescence at the single-cell level that is respon-
sible for cell-to-cell variation in replicative lifespan. In
individuals with DS, some of the manifestations of acceler-
ated aging have been attributed to an imbalance between
the first (dismutation) and second (conversion of hydrogen
Figure 1 Etiological hypothesis in abnormal immune response of Down syndrome. Abnormal immune host response, premature
ageing and environmental stimulation lead to a vicious circle, which finally occur to severe periodontal disease.
82 Y. Tanaka et al.peroxide to water by Gpx and catalase) step in pivotal
enzymatic pathway defending against ROS [77,81]. There
is one report that studied the influence of ROS on period-
ontitis of individuals with DS. It suggested that this might due
to the enzymatic ability of over-expressed CuZn-superoxide
dismutase in individuals with DS to catalyze the formation of
H2O2 from O2*, thereby increasing the availability of sub-
strate H2O2 for the iron-dependent generation of HO* via the
Fenton reaction, suggesting that HO* generated from DS-GF
may be involved in progressive periodontitis of DS [82].6. Conclusion
Many investigators have attempted to elucidate the imbal-
ance in oral phenomena in individuals with DS. The question
is why they have high prevalence of periodontal disease and
lower or equal prevalence of dental caries in comparison toTable 1 Characteristics of immunosenescence in general and DS
Cell type Characteristics
(number)
In general In DS
CD4+ # " #
CD8+ " " #
CD4+ CD8+(naı¨ve cell) #
CD4+ CD8+(memory cell) "
B lymphocytes (CD19+) # #
NK cell " "normal individuals. However, the opinion has been divided on
this question. In this review, we have attempted to hypothe-
size that accelerated ageing caused by telomere shortening
leads to immunodeficiency resulting in the imbalance in oral
phenomena in individuals with DS (Fig. 1). Unfortunately,
there are some negative views about the relations among
telomere shortening, ageing, and inflammation. However,
there are many positive reports to elucidate that telomere
shortening causes immune deficiency in the elderly and in
individuals with DS (Tables 1 and 2). Therefore, we cannot
deny our hypothesis, and we believe that this hypothesis will
be supported by sufficient evidence in the near future. In
addition, Sommer et al. [83] analyzed global changes of gene
expression in lymphocytes from children with DS by means of
the serial analysis of gene expression and indicated that
trisomy 21 induced a modest dysregulation of disomic genes
that might be related to the immunological perturbations
seen in DS. Therefore, further studies are needed to.
Publication
In general In DS
Haynes et al. [49] Franciotta et al. [41,84],
Cossarizza et al. [42]
Haynes and Maue [49] Francitta et al. [41,84],
Cossarizza et al. [42]
Guazzarotti et al. [44]
Guazzarotti et al. [44]
Frasca and Blomberg [52] Kusters et al. [40]
Borrego et al. [85] Cossarizza et al. [43]
Table 2 Ageing and telomere length in general and DS.
Cell type Telomere length
in general
Publication Telomere length
in DS
Publication Related disease
Lymphocytes Significantly
shortened
Slagboom
et al. [62]
Significantly
shortened
Jenkin et al. [71] Autoimmune disease,
infectious disease
Peripheral
blood cells
Significantly
shortened
Vaziri et al. [74] Significantly
shortened
Vaziri et al. [74] Autoimmune disease,
infectious disease
Hematopoietic
stem cell
Significantly
shortened
Vaziri et al. [61] Significantly
shortened
Holmes et al. [73] Hematopoietic
malignancies
Premature ageing and immune responses in the oral cavity of Down syndrome 83elucidate our hypothesis and should be discovered by genetic
and environmental background.
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